Latest News

NeuroVoices: Lily Sander on Advocacy, Community, and Raising Awareness for Charcot-Marie-Tooth Disease
NeuroVoices: Lily Sander on Advocacy, Community, and Raising Awareness for Charcot-Marie-Tooth Disease

March 19th 2025

Patient advocate and MDA Ambassador Lily Sander shared inspiring perspective on Charcot-Marie-Tooth disease, advocacy efforts, and the importance of connection

Fei Cao  (Credit: Genethon)
Early Trial Data Highlights Potential of Gene Therapy GNT0004 for Duchenne Muscular Dystrophy

March 18th 2025

 Lauren D’Angelo, MBA  (Credit: Alpha Cognition)
AChEI Inhibitor Benzgalantamine (Zunveyl) Commercially Launched for Mild to Moderate Alzheimer Disease

March 18th 2025

John J. Parent, MD, MSCR  (Credit: Indiana University School of Medicine)
Ifetroban Shows Promise in Slowing Cardiac Decline in Duchenne Muscular Dystrophy

March 18th 2025

New Post-Marketing Study to Test Omaveloxolone in Pregnant and Lactating Patients
New Post-Marketing Study to Test Omaveloxolone in Pregnant and Lactating Patients

March 18th 2025

Coverage of the 2025 ACTRIMS Forum

Get direct access to interviews with experts, as well as the latest data and clinical news updates, straight from the conference floor in West Palm Beach.

ACTRIMS 2025

Conference Coverage

View All
NeuroVoices: Lily Sander on Advocacy, Community, and Raising Awareness for Charcot-Marie-Tooth Disease
NeuroVoices: Lily Sander on Advocacy, Community, and Raising Awareness for Charcot-Marie-Tooth Disease

March 19th 2025

Fei Cao  (Credit: Genethon)
Early Trial Data Highlights Potential of Gene Therapy GNT0004 for Duchenne Muscular Dystrophy

March 18th 2025

Mechanism and Promise Behind Del-Zota for Duchenne Muscular Dystrophy: Michael Flanagan, PhD
Mechanism and Promise Behind Del-Zota for Duchenne Muscular Dystrophy: Michael Flanagan, PhD

March 18th 2025

John J. Parent, MD, MSCR  (Credit: Indiana University School of Medicine)
Ifetroban Shows Promise in Slowing Cardiac Decline in Duchenne Muscular Dystrophy

March 18th 2025

Video Series
Video Interviews
Podcasts

Most Recent

© 2025 MJH Life Sciences

All rights reserved.